RHD*609A,654C,667G,674T,807G
(ISBT table: not listed)
This entry is an RHD allele.
RHD(M218I, F223V, S225F,Y269X), RHD(T203T,M218I,F223V,S225F,Y269X), RHD(Y269X), RHD*609A,654C,667G,674T,807G, RHD*609G>A,654G>C,667T>G,674C>T,807T>G,
Molecular data
Nucleotides:
609G>A; 654G>C; 667T>G; 674C>T; 807T>G;
Amino acids: T203T; M218I; F223V; S225F; Y269*;
Hybrid allele encompassing at least one RHCE exon:
no
Comments on the molecular basis:
- see also "Additional comments" section on the RhesusBase http://www.rhesusbase.info/RHDRHD(M218I,F223V,S225F,Y269X).htm
Extracellular position of one or more amino acid substitutions:
Splicing:
Unconventional prediction methods:
Phenotype
Main D phenotype: unknown, expected to be D negative (last update: Nov. 17, 2019)Reports by D phenotype
Other RH phenotypes: RH:
Serology with monoclonal anti-D
Antigen Density (Ag/RBC)
More phenotype data
Rhesus Similarity Index
Haplotype
Main CcEe phenotype association: unknown (last update: Dec. 9, 2020)Alloimmunization
Antibodies in carriers
Antibody specificity: D (RH1)
Summary: probably D negative, at risk for anti-D (last update: Aug. 30, 2020)Detailed information
-
Dezan MR et al. Blood Cells Mol Dis (2017)
- Ab specificity: D (RH1)
- Number (auto- or allo-):
- Number listed as allo-: 1 sample, heterozygous with RHef00442
- Number listed as auto-:
- Number of carriers of the allele assessed:
- DAT: 46.2% of D+ patients with anti-D in this study had positive DAT (which patients are not specified)
- Autologuous control: ND
- Elution: ND
- Autoadsorption: ND
- Titer: ND
- Was anti-LW excluded?: ND
- Other antibodies detected: allo-anti-E
- Cross matches (with Ab and RBCs from different partial types): ND
- Transfusion history: yes, number and phenotypes ND
- Pregnancy history:
- Anti-D Ig history: ND, probably none
- Context: SCD patient
- Hemolytic consequences:
- Comment: 1 sample heterozygous with RHef00442 in trans, listed as allo-anti-D; authors underline that "self-directed anti-D may have been missed"
Antibodies in D negative recipients
Alloimmunization in recipients: not expected, see phenotype data
Reports
Summary: exceptional description(s), possibly in the German population (last update: Dec. 22, 2019)Structure mapping
Movement | Mouse Input | Touch Input | ||
---|---|---|---|---|
Rotation | Primary Mouse Button | Single touch | ||
Translation | Middle Mouse Button or Ctrl+Primary | Triple touch | ||
Zoom | Scroll Wheel or Second Mouse Button or Shift+Primary | Pinch (double touch) | ||
Slab | Ctrl+Second | Not Available |
References
- National Center for Biotechnology Information et al. Data from Genbank submission Online ressource, 1982. — Online ressource — [RHeference]
- Wagner FF and Flegel WA et al. The Human RhesusBase Online ressource, 2011. — Online ressource — [RHeference]
- Dezan MR et al. RHD and RHCE genotyping by next-generation sequencing is an effective strategy to identify molecular variants within sickle cell disease patients. Blood Cells Mol Dis, 2017. [Citation] [RHeference]
- Floch A et al. Comment from Rheference Online ressource, 2020. — Online ressource — [RHeference]
Last update: Nov. 4, 2019